345
Participants
Start Date
April 30, 2025
Primary Completion Date
August 31, 2028
Study Completion Date
May 25, 2029
RO7673396
RO7673396 will be administered as per the schedule specified in the protocol.
RECRUITING
New Zealand Clinical Research - Auckland, Auckland
RECRUITING
St Vincent's Hospital Sydney, Darlinghurst
RECRUITING
Peter MacCallum Cancer Center, Parkville
RECRUITING
New Zealand Clinical Research - Christchurch, Christchurch
RECRUITING
National Taiwan University Hospital, Taipei
RECRUITING
Florida Cancer Specialists - Sarasota (North Catttlemen Rd), Sarasota
RECRUITING
National Cheng Kung University Hospital, Tainan City
RECRUITING
City of Hope Comprehensive Cancer Center, Duarte
RECRUITING
National Cancer Centre - 30 Hospital Blvd, Singapore
RECRUITING
Fudan University Shanghai Cancer Center, Shanghai
RECRUITING
Hubei Cancer Hospital, Wuhan
RECRUITING
Sun yat-sen University Cancer Center, Guangzhou
RECRUITING
Sun Yat-Sen University Cancer Center - Huangpu Campus, Guangzhou
RECRUITING
Smilow Cancer Hospital at Yale New Haven, New Haven
RECRUITING
MD Anderson Cancer Center, Houston
RECRUITING
South Texas Accelerated Research Therapeutics (START), San Antonio
RECRUITING
Princess Margaret Hospital, Toronto
RECRUITING
Prince of Wales Hospital, Hong Kong
Hoffmann-La Roche
INDUSTRY